Breaking News Instant updates and real-time market news.

AERI

Aerie Pharmaceuticals

$51.65

-4.45 (-7.93%)

16:06
08/08/17
08/08
16:06
08/08/17
16:06

Aerie Pharmaceuticals comments on status of contract manufacturer for Rhopressa

Aerie Pharmaceuticals has received notification by its contract drug product manufacturer that the contract manufacturer has received a Complete Response Letter from the FDA, regarding the contract manufacturer's New Drug Application for one of their own product candidates, and which refers to a Current Good Manufacturing Practice inspection at the facility. The contract manufacturer will work with the FDA to determine the appropriate next steps. This facility also manufactures on a contract basis Aerie's product candidate Rhopressa, which has a Prescription Drug User Fee Act goal date of February 28, 2018. Aerie currently believes it is probable that open issues will be resolved prior to the February 28, 2018 PDUFA date for Rhopressa.

  • 09

    Aug

  • 28

    Feb

AERI Aerie Pharmaceuticals
$51.65

-4.45 (-7.93%)

04/13/17
HCWC
04/13/17
NO CHANGE
Target $42
HCWC
Buy
Aerie pullback on hyperemia increase an overreaction, says H.C. Wainwright
H.C. Wainwright analyst Corey Davis said despite the "positive" safety and efficacy data Aerie Pharmaceuticals' reported from its trial of Rhopressa, "focus for the Street" was clearly on the 48% hyperemia rate and 31% discontinuation rate. However, the rate of events outside of hyperemia is relatively comparable to that seen with approved products Lumigan and Travatan and mild redness is likely of little real-world concern in a condition as serious as glaucoma, he tells investors. The analyst, who sees the first-read response in the shares as an overreaction, has a Buy rating and $69 price target on Aerie shares, which are down about 1% to $42 in pre-market trading after suffering a sharper decline in after-market trading last night.
05/25/17
COWN
05/25/17
NO CHANGE
Target $100
COWN
Outperform
Aerie Pharmaceuticals probability of a takeout increasing, says Cowen
Cowen analyst Tyler Van Buren noted the Aerie Pharmaceuticals Roclatan trial was successful and appears approvable as the first FDA approved prostaglandin product. He also noted its Rhopressa drug which is also under review appears approvable as well and combined, the drugs represent a $1.5B long duration opportunity. The analyst believes Aerie is a prime consolidation candidate and said it is not unreasonable to put a 4x multiple on peak sales of $1.5B arrives at a $130-$140 per shares valuation. Van Buren reiterated his Outperform rating and raised his price target to $100 from $70 on Aerie Pharmaceuticals shares.
05/25/17
NEED
05/25/17
NO CHANGE
Target $65
NEED
Buy
Aerie Pharmaceuticals price target raised to $65 from $58 at Needham
Needham analyst Serge Belanger raised his price target for Aerie Pharmaceuticals to $65 saying the company reported positive results from Mercury-2, the second of two Phase 3 trials evaluating Roclatan as treatment for glaucoma. Once again, Roclatan met all its endpoints, Belanger tells investors in a research note. The data are a "key derisking event" for the program, the analyst adds. He keeps a Buy rating on Aerie.
07/03/17
ADAM
07/03/17
NO CHANGE
Target $65
ADAM
Buy
Aerie price target raised to $65 from $60 at Canaccord
Canaccord analyst Dewey Steadman said he remains confident in Aerie Pharmaceuticals' ability to launch Rhopressa as early at the first half of next year, noting that the company is preparing for an FDA advisory committee meeting that could happen before Thanksgiving. Steadman, who sees Rhopressa as a $500M product at its peak, also said he's confident in a potential Roclatan approval in 2019, stating that could be a $1B product. The analyst keeps a Buy rating on Aerie shares and raised his price target on the stock to $65 from $60.

TODAY'S FREE FLY STORIES

PTC

PTC

$97.72

-0.08 (-0.08%)

12:07
06/19/18
06/19
12:07
06/19/18
12:07
Hot Stocks
PTC, Elysium announce new design, validation app for ThingWorx Navigate »

PTC announced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMI

Kinder Morgan

$17.21

0.04 (0.23%)

12:05
06/19/18
06/19
12:05
06/19/18
12:05
Options
Kinder Morgan call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMUS

T-Mobile

$60.53

0.16 (0.27%)

, S

Sprint

$5.56

0.01 (0.18%)

12:03
06/19/18
06/19
12:03
06/19/18
12:03
Hot Stocks
T-Mobile, Sprint officially file merger plans with FCC »

T-Mobile US (TMUS) and…

TMUS

T-Mobile

$60.53

0.16 (0.27%)

S

Sprint

$5.56

0.01 (0.18%)

DTEGY

Deutsche Telekom

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$195.71

-2.59 (-1.31%)

12:01
06/19/18
06/19
12:01
06/19/18
12:01
Periodicals
Facebook misses 'deadline' to answer Senator's questions, Bloomberg says »

Facebook has missed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

TCI

Transcontinental Realty Inc

$36.00

2.54 (7.59%)

12:00
06/19/18
06/19
12:00
06/19/18
12:00
Hot Stocks
Transcontinental Realty, Adobe Properties say advisor may make stock purchases »

Transcontinental Realty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMAR

Smartsheet

$29.00

-3.07 (-9.57%)

12:00
06/19/18
06/19
12:00
06/19/18
12:00
Hot Stocks
Smartsheet falls -9.9% »

Smartsheet is down -9.9%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYX

Systemax

$35.40

-4 (-10.15%)

12:00
06/19/18
06/19
12:00
06/19/18
12:00
Hot Stocks
Systemax falls -10.5% »

Systemax is down -10.5%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTX

United Technologies

$125.30

-2.2 (-1.73%)

, EADSY

Airbus

$0.00

(0.00%)

12:00
06/19/18
06/19
12:00
06/19/18
12:00
Periodicals
Pratt & Whitney close to fix for part that delayed Airbus jets, Bloomberg says »

Pratt & Whitney,…

UTX

United Technologies

$125.30

-2.2 (-1.73%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAGS

PagSeguro Digital

$27.24

-4.92 (-15.30%)

12:00
06/19/18
06/19
12:00
06/19/18
12:00
Hot Stocks
PagSeguro Digital falls -15.1% »

PagSeguro Digital is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

EBR

Centrais Electricas

$3.71

0.21 (6.00%)

12:00
06/19/18
06/19
12:00
06/19/18
12:00
Hot Stocks
Centrais Electricas rises 6.3% »

Centrais Electricas is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$10.44

0.795 (8.24%)

12:00
06/19/18
06/19
12:00
06/19/18
12:00
Hot Stocks
ProShares Trust Ultra VIX Short Term Futures ETF rises 8.0% »

ProShares Trust Ultra VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COTV

Cotiviti Holdings

$44.02

4.13 (10.35%)

12:00
06/19/18
06/19
12:00
06/19/18
12:00
Hot Stocks
Cotiviti Holdings rises 10.4% »

Cotiviti Holdings is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARRY

Array BioPharma

$17.90

0.4 (2.29%)

11:57
06/19/18
06/19
11:57
06/19/18
11:57
Conference/Events
Array BioPharma to hold a conference call »

In conjunction with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 30

    Jun

  • 30

    Jun

VZ

Verizon

$48.69

1.23 (2.59%)

11:57
06/19/18
06/19
11:57
06/19/18
11:57
Periodicals
Verizon to cease sharing phone-location data of customers, Reuters reports »

Verizon will stop sharing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

USCR

U.S. Concrete

$63.30

-1.1 (-1.71%)

11:53
06/19/18
06/19
11:53
06/19/18
11:53
Hot Stocks
U.S. Concrete rating downgraded to B2 from B1 by Moody's »

Moody's Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

JD

JD.com

$41.57

-2.18 (-4.98%)

11:50
06/19/18
06/19
11:50
06/19/18
11:50
Options
Continued interest in JD Jun 22nd 45 calls even as shares slide »

Continued interest in JD…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:50
06/19/18
06/19
11:50
06/19/18
11:50
General news
Treasury's bill auctions were about average »

Treasury's bill…

KO

Coca-Cola

$43.57

0.01 (0.02%)

11:47
06/19/18
06/19
11:47
06/19/18
11:47
Hot Stocks
Arby's announces conversion to Coca-Cola beverages »

Arby's announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOX

21st Century Fox

$44.44

0.09 (0.20%)

, FOXA

21st Century Fox

$44.70

0.145 (0.33%)

11:43
06/19/18
06/19
11:43
06/19/18
11:43
Hot Stocks
21st Century Fox says 'looks forward' to final decision clearing transaction »

21st Century Fox (FOXA)…

FOX

21st Century Fox

$44.44

0.09 (0.20%)

FOXA

21st Century Fox

$44.70

0.145 (0.33%)

SKYAY

Sky

$0.00

(0.00%)

DIS

Disney

$106.00

-1.05 (-0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEA

China Eastern Airlines

$42.19

-0.49 (-1.15%)

, EADSY

Airbus

$0.00

(0.00%)

11:41
06/19/18
06/19
11:41
06/19/18
11:41
Periodicals
China Eastern calls for bids to supply 150 jetliners, Reuters says »

China Eastern (CEA) is…

CEA

China Eastern Airlines

$42.19

-0.49 (-1.15%)

EADSY

Airbus

$0.00

(0.00%)

BA

Boeing

$343.13

-11.66 (-3.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$161.63

56.15 (53.23%)

11:40
06/19/18
06/19
11:40
06/19/18
11:40
Options
Sarepta Therapeutics call buyer hits a home run »

Sarepta Therapeutics call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

11:40
06/19/18
06/19
11:40
06/19/18
11:40
General news
Atlanta Fed's Q2 GDPNow estimate was nudged down to 4.7% »

Atlanta Fed's Q2…

ADTN

Adtran

$15.25

-0.25 (-1.61%)

11:38
06/19/18
06/19
11:38
06/19/18
11:38
Hot Stocks
Adtran enters partnership with Open Networking Foundation »

Adtran announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACHV

Achieve Life Sciences

$3.45

-0.08 (-2.27%)

11:38
06/19/18
06/19
11:38
06/19/18
11:38
Hot Stocks
Breaking Hot Stocks news story on Achieve Life Sciences  »

Sabby Management reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:37
06/19/18
06/19
11:37
06/19/18
11:37
General news
4-Week Bill Auction Total Amount data reported »

4-Week Bill Auction Total…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.